{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T11:10:02Z","timestamp":1756033802699,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,24]]},"DOI":"10.7759\/cureus.90863","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T10:32:43Z","timestamp":1756031563000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Allergic Bronchopulmonary Aspergillosis in Bronchial Asthma Patients: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Arnab","family":"Swain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2262","article-title":"Treatment strategies for allergy and asthma","volume":"8","author":"Holgate ST","year":"2008","unstructured":"Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008, 8:218-30. 10.1038\/nri2262","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.504752","article-title":"Severe asthma and fungi: current evidence","volume":"49 Suppl 1","author":"Agarwal R","year":"2011","unstructured":"Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011, 49 Suppl 1:S150-7. 10.3109\/13693786.2010.504752","journal-title":"Med Mycol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning DW","year":"2013","unstructured":"Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013, 51:361-70. 10.3109\/13693786.2012.738312","journal-title":"Med Mycol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2015.7.3.205","article-title":"Mold allergens in respiratory allergy: from structure to therapy","volume":"7","author":"Twaroch TE","year":"2015","unstructured":"Twaroch TE, Curin M, Valenta R, Swoboda I. Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res. 2015, 7:205-20. 10.4168\/aair.2015.7.3.205","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.06.006","article-title":"Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium","volume":"10","author":"Reihill JA","year":"2011","unstructured":"Reihill JA, Moore JE, Elborn JS, Ennis M. Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium. J Cyst Fibros. 2011, 10:401-6. 10.1016\/j.jcf.2011.06.006","journal-title":"J Cyst Fibros"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202109-2205PP","article-title":"Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes","volume":"205","author":"Reddel HK","year":"2022","unstructured":"Reddel HK, Bacharier LB, Bateman ED, et al.. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Am J Respir Crit Care Med. 2022, 205:17-35. 10.1164\/rccm.202109-2205PP","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller MR","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al.. Standardisation of spirometry. Eur Respir J. 2005, 26:319-38. 10.1183\/09031936.05.00034805","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2018.04.007","article-title":"Prevalence of allergic bronchopulmonary aspergillosis in asthmatic patients: a prospective institutional study","volume":"65","author":"Kalaiyarasan","year":"2018","unstructured":"Kalaiyarasan, Jain AK, Puri M, Tayal D, Singhal R, Sarin R. Prevalence of allergic bronchopulmonary aspergillosis in asthmatic patients: a prospective institutional study. Indian J Tuberc. 2018, 65:285-9. 10.1016\/j.ijtb.2018.04.007","journal-title":"Indian J Tuberc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijaai.ijaai_18_18","article-title":"Clinical, radiological, and microbiological profile of pulmonary aspergillosis in treated cases of pulmonary tuberculosis","volume":"32","author":"Jain S","year":"2018","unstructured":"Jain S, Rathore YS, Joshi V, et al.. Clinical, radiological, and microbiological profile of pulmonary aspergillosis in treated cases of pulmonary tuberculosis. Indian J Allergy Asthma Immunol. 2018, 32:74-7. 10.4103\/ijaai.ijaai_18_18","journal-title":"Indian J Allergy Asthma Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2016-000155","article-title":"Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan","volume":"3","author":"Iqbal N","year":"2016","unstructured":"Iqbal N, Irfan M, Zubairi AB, Jabeen K, Awan S, Khan JA. Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan. BMJ Open Respir Res. 2016, 3:e000155. 10.1136\/bmjresp-2016-000155","journal-title":"BMJ Open Respir Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.4103\/0972-6691.178269","article-title":"An observational study of bronchial asthma in 6-12 years school going children of Agra district","volume":"29","author":"Amir M","year":"2015","unstructured":"Amir M, Kumar S, Gupta RK, et al.. An observational study of bronchial asthma in 6-12 years school going children of Agra district. Indian J Allergy Asthma Immunol. 2015, 29:62-6.","journal-title":"Indian J Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson DD","year":"2006","unstructured":"Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006, 118:773-86; quiz 787-8. 10.1016\/j.jaci.2006.07.024","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104716","article-title":"Asthma: mechanisms of disease persistence and progression","volume":"22","author":"Cohn L","year":"2004","unstructured":"Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004, 22:789-815. 10.1146\/annurev.immunol.22.012703.104716","journal-title":"Annu Rev Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053614","article-title":"CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma","volume":"354","author":"Akbari O","year":"2006","unstructured":"Akbari O, Faul JL, Hoyte EG, et al.. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med. 2006, 354:1117-29. 10.1056\/NEJMoa053614","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.169","article-title":"The role of T lymphocytes in the pathogenesis of asthma","volume":"111","author":"Larch\u00e9 M","year":"2003","unstructured":"Larch\u00e9 M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003, 111:450-63; quiz 464. 10.1067\/mai.2003.169","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.42.111901.111143","article-title":"Cytokine modulators as novel therapies for asthma","volume":"42","author":"Barnes PJ","year":"2002","unstructured":"Barnes PJ. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol. 2002, 42:81-98. 10.1146\/annurev.pharmtox.42.111901.111143","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.139","article-title":"Chemokines in asthma: cooperative interaction between chemokines and IL-13","volume":"111","author":"Zimmermann N","year":"2003","unstructured":"Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol. 2003, 111:227-42; quiz 243. 10.1067\/mai.2003.139","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.034","article-title":"The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?","volume":"114","author":"Robinson DS","year":"2004","unstructured":"Robinson DS. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?. J Allergy Clin Immunol. 2004, 114:58-65. 10.1016\/j.jaci.2004.03.034","journal-title":"J Allergy Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli SJ","year":"2005","unstructured":"Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005, 23:749-86. 10.1146\/annurev.immunol.21.120601.141025","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.60","article-title":"Mast cells: beyond IgE","volume":"111","author":"Boyce JA","year":"2003","unstructured":"Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol. 2003, 111:24-32; quiz 33. 10.1067\/mai.2003.60","journal-title":"J Allergy Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"Brightling CE","year":"2002","unstructured":"Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002, 346:1699-705. 10.1056\/NEJMoa012705","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01095.x","article-title":"Are eosinophils still important in asthma?","volume":"31","author":"Chu HW","year":"2001","unstructured":"Chu HW, Martin RJ. Are eosinophils still important in asthma?. Clin Exp Allergy. 2001, 31:525-8. 10.1046\/j.1365-2222.2001.01095.x","journal-title":"Clin Exp Allergy"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00092.x","article-title":"The role of eosinophils and neutrophils in inflammation","volume":"30 Suppl 1","author":"Sampson AP","year":"2000","unstructured":"Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy. 2000, 30 Suppl 1:22-7. 10.1046\/j.1365-2222.2000.00092.x","journal-title":"Clin Exp Allergy"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.48895","article-title":"Allergic bronchopulmonary aspergillosis: a review of 42 patients from a tertiary care center in India","volume":"26","author":"Prasad R","year":"2009","unstructured":"Prasad R, Garg R, Sanjay, Shukla AD. Allergic bronchopulmonary aspergillosis: a review of 42 patients from a tertiary care center in India. Lung India. 2009, 26:38-40. 10.4103\/0970-2113.48895","journal-title":"Lung India"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie MJ","year":"2000","unstructured":"Leckie MJ, ten Brinke A, Khan J, et al.. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000, 356:2144-8. 10.1016\/S0140-6736(00)03496-6","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation","volume":"95","author":"Fahy JV","year":"1995","unstructured":"Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995, 95:843-52. 10.1016\/s0091-6749(95)70128-1","journal-title":"J Allergy Clin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma","volume":"160","author":"Jatakanon A","year":"1999","unstructured":"Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999, 160:1532-9. 10.1164\/ajrccm.160.5.9806170","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel SE","year":"2006","unstructured":"Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006, 368:804-13. 10.1016\/S0140-6736(06)69290-8","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9610046","article-title":"Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids","volume":"156","author":"Wenzel SE","year":"1997","unstructured":"Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997, 156:737-43. 10.1164\/ajrccm.156.3.9610046","journal-title":"Am J Respir Crit Care Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.09.010","article-title":"The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma","volume":"16","author":"Kuipers H","year":"2004","unstructured":"Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol. 2004, 16:702-8. 10.1016\/j.coi.2004.09.010","journal-title":"Curr Opin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367440-prevalence-of-allergic-bronchopulmonary-aspergillosis-in-bronchial-asthma-patients-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T10:32:44Z","timestamp":1756031564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367440-prevalence-of-allergic-bronchopulmonary-aspergillosis-in-bronchial-asthma-patients-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.90863","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}